Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Pathologic evaluation of malignant pleural mesothelioma.
Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
Transcriptome sequencing of malignant pleural mesothelioma tumors.
A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.
Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases.
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
Malignant pleural mesothelioma.
Second generation sequencing of the mesothelioma tumor genome.
Characteristics of malignant pleural mesothelioma in women.
p16 Deletion in sarcomatoid tumors of the lung and pleura.
Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma.
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma.
Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma.
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.
The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma.
Integrative Molecular Characterization of Malignant Pleural Mesothelioma.